From cognitive screening to digital phenotyping: rethinking early detection of cognitive impairment in primary care - Scorecard - MDSpire

From cognitive screening to digital phenotyping: rethinking early detection of cognitive impairment in primary care

  • By

  • Miren Altuna

  • July 7, 2026

  • 0 min

Share

Clinical Scorecard: Transforming Cognitive Assessment: Innovating Early Identification of Cognitive Decline in Primary Care Settings

At a Glance

CategoryDetail
ConditionCognitive Impairment
Key MechanismsEarly detection and assessment of cognitive decline using various cognitive screening tools and digital phenotyping.
Target PopulationIndividuals with early cognitive symptoms, particularly in primary care settings.
Care SettingPrimary care

Key Highlights

  • Early detection of cognitive impairment is a public health priority.
  • Traditional cognitive screening tools have limitations in identifying subtle cognitive decline.
  • Digital cognitive assessment may enhance early risk stratification and monitoring.
  • A staged pathway combining various assessment methods is proposed for better detection.
  • Primary care is crucial for identifying early cognitive symptoms before referral to specialists.

Guideline-Based Recommendations

Diagnosis

  • Use a combination of brief cognitive instruments, informant measures, and functional assessments.

Management

  • Incorporate biological markers and neuropsychiatric assessments in the diagnostic pathway.

Monitoring & Follow-up

  • Utilize digital tools for repeated assessments and longitudinal monitoring of cognitive changes.

Risks

  • Educational and cultural biases may affect the interpretation of cognitive test scores.

Patient & Prescribing Data

Individuals presenting with memory concerns or subtle cognitive changes.

Early identification can inform prognosis, follow-up, and therapeutic planning.

Clinical Best Practices

  • Integrate subjective concerns and informant-reported changes with cognitive assessments.
  • Use functional measures to distinguish between mild cognitive impairment and dementia.
  • Consider neuropsychiatric symptoms that may accompany cognitive decline.

Related Resources & Content

Original Source(s)

From cognitive screening to digital phenotyping: rethinking early detection of cognitive impairment in primary care

  • by Miren Altuna

  • July 7, 2026

Related Content

ACP Ranks Obesity Drug Options

A living clinical guideline outlines a treatment hierarchy for selected pharmacologic therapies in patients with obesity and selected patients with overweight.

Does TYK2/JAK1 Show Potential in Inflammatory Diseases?

Investigational inhibitor was not associated with treatment-related serious adverse events and produced biomarker changes consistent with pathway inhibition in healthy volunteers.

Individually tailored physiotherapy interventions for pregnancy-related pelvic girdle pain: functioning, physical activity, and treatment satisfaction four months postpartum. A cross-sectional study